黄金城集团

资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting

The Journal of Infectious Diseases. 2021-01; 
Hicks SM, Pohl K, Neeman T, McNamara HA, Parsons KM, He JS, Ali SA, Nazir S, Rowntree LC, Nguyen THO, Kedzierska K, Doolan DL, Vinuesa CG, Cook MC, Coatsworth N, Myles PS, Kurth F, Sander LE, Mann GJ, Gruen RL, George AJ, Gardiner EE, Cockburn IA, SARS-CoV-2 Testing in Elective Surgery Collaborators.
Products/Services Used Details Operation
Catalog Antibody 500 ng/mL S1 Spike domain (GenScript Biotech, Piscataway, NJ, USA; Z03501) Spike receptor binding domain (RBD; GenScript Biotech, Z03483) or Nucleocapsid (GenScript Biotech, D o w l n o a d e d f r o Get A Quote

摘要

关键词